Use Kahzam Inc. historical price analysis together with your assets to offset short term systematic risk or to hedge overall market volatility as well as to check it against diversification policy that fits your risk preferences.
By David Fry (ETF Digest ): In the mid-1980s discoveries in biotechnology were revealed and investors piled-into many new companies like Genentech and Amgen. But the technology was yet to produce profits for many years to come. Mutual fund companies devoted some funds to this new area of investment but it took over a decade before the sector started to produce results. ETFs IBB and XBI naturally were to follow but not until early in the last decade. Initial investors in the area were too soon and many lost money and became...